Westfield Capital Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-479,467
| Closed | -$21M | – | 231 |
|
|
2022
Q4 | $21M | Sell |
479,467
-324,176
| -40% | -$14.2M | 0.16% | 157 |
|
|
2022
Q3 | $53M | Sell |
803,643
-581,167
| -42% | -$38.3M | 0.42% | 93 |
|
|
2022
Q2 | $69.9M | Buy |
1,384,810
+211,389
| +18% | +$10.7M | 0.55% | 64 |
|
|
2022
Q1 | $75M | Buy |
1,173,421
+74,730
| +7% | +$4.77M | 0.48% | 74 |
|
|
2021
Q4 | $118M | Sell |
1,098,691
-116,662
| -10% | -$12.5M | 0.7% | 42 |
|
|
2021
Q3 | $125M | Buy |
1,215,353
+35,234
| +3% | +$3.62M | 0.75% | 36 |
|
|
2021
Q2 | $104M | Buy |
1,180,119
+51,632
| +5% | +$4.54M | 0.62% | 50 |
|
|
2021
Q1 | $110M | Buy |
1,128,487
+260,420
| +30% | +$25.3M | 0.68% | 46 |
|
|
2020
Q4 | $97.4M | Sell |
868,067
-192,731
| -18% | -$21.6M | 0.58% | 57 |
|
|
2020
Q3 | $98.3M | Buy |
1,060,798
+8,615
| +0.8% | +$799K | 0.64% | 51 |
|
|
2020
Q2 | $82.1M | Buy |
1,052,183
+27,576
| +3% | +$2.15M | 0.56% | 56 |
|
|
2020
Q1 | $59.9M | Buy |
1,024,607
+253,971
| +33% | +$14.9M | 0.53% | 66 |
|
|
2019
Q4 | $61.7M | Sell |
770,636
-76,323
| -9% | -$6.11M | 0.44% | 81 |
|
|
2019
Q3 | $62.2M | Buy |
846,959
+234,579
| +38% | +$17.2M | 0.5% | 70 |
|
|
2019
Q2 | $57.8M | Buy |
612,380
+145,339
| +31% | +$13.7M | 0.43% | 77 |
|
|
2019
Q1 | $37.4M | Sell |
467,041
-115,785
| -20% | -$9.27M | 0.28% | 117 |
|
|
2018
Q4 | $31.4M | Buy |
582,826
+73,446
| +14% | +$3.96M | 0.27% | 118 |
|
|
2018
Q3 | $39.8M | Buy |
509,380
+296,400
| +139% | +$23.1M | 0.28% | 121 |
|
|
2018
Q2 | $13.5M | Buy |
+212,980
| New | +$13.5M | 0.1% | 197 |
|